pubmed.ncbi.nlm.nih.gov

Aquaporin-2 regulation in health and disease - PubMed

Review

Aquaporin-2 regulation in health and disease

M Judith Radin et al. Vet Clin Pathol. 2012 Dec.

Abstract

Aquaporin-2 (AQP2), the vasopressin-regulated water channel of the renal collecting duct, is dysregulated in numerous disorders of water balance in people and animals, including those associated with polyuria (urinary tract obstruction, hypokalemia, inflammation, and lithium toxicity) and with dilutional hyponatremia (syndrome of inappropriate antidiuresis, congestive heart failure, cirrhosis). Normal regulation of AQP2 by vasopressin involves 2 independent regulatory mechanisms: (1) short-term regulation of AQP2 trafficking to and from the apical plasma membrane, and (2) long-term regulation of the total abundance of the AQP2 protein in the cells. Most disorders of water balance are the result of dysregulation of processes that regulate the total abundance of AQP2 in collecting duct cells. In general, the level of AQP2 in a collecting duct cell is determined by a balance between production via translation of AQP2 mRNA and removal via degradation or secretion into the urine in exosomes. AQP2 abundance increases in response to vasopressin chiefly due to increased translation subsequent to increases in AQP2 mRNA. Vasopressin-mediated regulation of AQP2 gene transcription is poorly understood, although several transcription factor-binding elements in the 5' flanking region of the AQP2 gene have been identified, and candidate transcription factors corresponding to these elements have been discovered in proteomics studies. Here, we review progress in this area and discuss elements of vasopressin signaling in the collecting duct that may impinge on regulation of AQP2 in health and in the context of examples of polyuric diseases.

© 2012 American Society for Veterinary Clinical Pathology.

PubMed Disclaimer

Figures

Figure 1
Figure 1

Processes that determine AQP2 levels in collecting duct cells. See text for explanation.

Similar articles

Cited by

References

    1. DiBartola SP. Hyponatremia. Vet Clin North Am Small Anim Pract. 1998;28:515–532. - PubMed
    1. Nichols R. Polyuria and polydipsia. Diagnostic approach and problems associated with patient evaluation. Vet Clin North Am Small Anim Pract. 2001;31:833–844. v. - PubMed
    1. O'Leary CA, Duffy D, Biros I, Corley S. Linkage confirms canine pkd1 orthologue as a candidate for bull terrier polycystic kidney disease. Anim Genet. 2009;40:543–546. - PubMed
    1. Young AE, Biller DS, Herrgesell EJ, Roberts HR, Lyons LA. Feline polycystic kidney disease is linked to the PKD1 region. Mamm Genome. 2005;16:59–65. - PubMed
    1. Torres VE, Meijer E, Bae KT, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang JJ, Czerwiec FS. Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3–4 Study. Am J Kidney Dis. 2011;57:692–699. - PubMed

Publication types

MeSH terms

Substances